Danaparoid and pneumonia Patient Reports February 12, 2012

Danaparoid Side Effects Report #6137736-0
Danaparoid side effect was reported by a Consumer or non-health professional from AUSTRALIA on Mar 20, 2009. Male patient, 44 years of age, was diagnosed with thrombosis prophylaxis and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: pneumonia , septic shock. Danaparoid dosage: unknown. Patient died.

Danaparoid Side Effects Report #5135919-X
Danaparoid side effect was reported by a Consumer or non-health professional from ISRAEL on Oct 12, 2006. Female patient, 63 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, platelet count decreased, pneumonia , thrombosis. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, NOREPINEPHRINE BITARTRATE, OXACILLIN, AMIODARONE. Patient recovered.

Danaparoid Side Effects Report #5115444-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 13, 2006. Female patient, 89 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: diabetes mellitus, gastric haemorrhage, hypertension, pneumonia , renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, GABEXATE MESILATE, DOPAMINE, CARPERITIDE, INSULIN, FUROSEMIDE, MIDAZOLAM, CEFOTIAM HYDROCHLORIDE. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5033185-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2006. Female patient, 89 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, gastric haemorrhage, pneumonia . Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, GABEXATE MESILATE, DOPAMINE, CARPERITIDE, INSULIN, FUROSEMIDE, MIDAZOLAM, CEFOTIAM HYDROCHLORIDE. Patient was hospitalized. Patient died.


Danaparoid Side Effects Report #5124738-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 85 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, lung disorder, pneumonia . Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, CLINDAMYCIN PHOSPHAGE, MINOCYCLINE HYDROCHLORIDE, ARBEKACIN SULPHATE, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, PHENYTOIN, SIVELESTAT. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5024706-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Female patient, 85 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, lung disorder, pneumonia . Danaparoid dosage: unknown. During the same period patient was treated with UNASYN, CLINDAMYCIN, MINOCYCLINE HYDROCHLORIDE, ARBEKACIN, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, PHENYTOIN, SILVELESTAT. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5030495-4
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Female patient, 85 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, lung disorder, pneumonia . Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, CLINDAMYCIN PHOSPHATE, MINOCYCLINE HYDROCHLORIDE, ARBEKACIN SULPHATE, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, PHENYTOIN, SIVELESTAT. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5118898-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood urea increased, condition aggravated, haemoglobin decreased, pneumonia , upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with DORIPENEM HYDRATE, ROXATIDINE ACETATE. Patient died.

Danaparoid Side Effects Report #5006923-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 09, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemoglobin decreased, pneumonia , upper gastrointestinal haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with DORIPENEM HYDRATE, ROXATIDINE ACETATE. Patient died.


Danaparoid Side Effects Report #5046810-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 23, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, haemoglobin decreased, hepatic function abnormal, pneumonia , renal impairment, upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with DORIPENEM HYDRATE, ROXATIDINE ACETATE. Patient died.

Danaparoid Side Effects Report #4708673-0
Danaparoid side effect was reported by a Physician from JAPAN on June 28, 2005. Male patient, 71 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, gastritis haemorrhagic, hyperbilirubinaemia, pneumonia . Danaparoid dosage: unknown. During the same period patient was treated with NICORANDIL, BISOPROLOL FUMARATE, NIFEDIPINE, ISOSORBIDE MONONITRATE, LANSOPRAZOLE, CARBOCISTEINE. Patient died.

Danaparoid Side Effects Report #4802369-2
Danaparoid side effect was reported by a Consumer or non-health professional from NETHERLANDS on Sept 29, 2005. Male patient, 69 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: heparin-induced thrombocytopenia, peripheral ischaemia, pneumonia , pulse absent, thrombosis, white clot syndrome. Danaparoid dosage: unknown. During the same period patient was treated with METOPROLOL, RANITIDINE, DIAZEPAM, GLYCERYL TRINITRATE, HEPARIN, ILOPROST, ACENOCOUMAROL. Patient was hospitalized. Patient recovered.